Viyash Scientific Limited (BOM:512529)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	34.20B	15.51B	13.70B	14.21B	14.13B
Pharmaceuticals Growth	120.47%	13.26%	-3.60%	0.57%	3.76%
Total	34.20B	15.51B	13.70B	14.21B	14.13B
Total Growth	120.47%	13.26%	-3.60%	0.57%	3.76%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Europe	7.00B	5.72B	5.76B	5.94B
Europe Growth	22.50%	-0.68%	-3.15%	-4.86%
Asia	4.45B	3.30B	4.76B	3.90B
Asia Growth	34.78%	-30.70%	22.16%	0.32%
Rest of the World	4.06B	4.68B	3.69B	4.29B
Rest of the World Growth	-13.20%	26.82%	-13.90%	23.06%
Total	15.51B	13.70B	14.21B	14.13B
Total Growth	13.26%	-3.60%	0.57%	3.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error